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Most erythropoietin (Ep) preparations contain non-erythropoietin contaminants. The use of
such hormone concentrates raises important questions regarding interpretations of results
derived from in vivo and especially from in vitro studies. By sterilizing various Ep preparations
with Nalgene, Millipore, or Selas silver filtration, or even after conventional membrane dialysis,
variable responses were noted when the Ep was assayed with mouse bone marrow cells in vitro
(i.e., by stimulating the production of erythroid colonies from CFU-e and BFU-e) and in vivo
(i.e., by using the exhypoxic, polycythemic mouse bioassay for Ep). The utility and limitations
of such preparative procedures are discussed.
INTRODUCTION
Urine from anemic patients and plasma from anemic animals have long served as
sources of erythropoietin (Ep), the hormone which specifically regulates erythropoie-
sis. During the last two decades, simple as well as complex biochemical and
biophysical procedures have been employed to purify this glycoprotein. Procedures
such as precipitation with ethanol, acetone, tannic acid, and benzoic acid have
proven useful in concentrating the hormone. Other techniques such as flash evapora-
tion, ultrafiltration, selective dialysis against drying agents, DEAE-cellulose chro-
matography, and adsorption and elution from kaolin have also been used [1-3].
Purification of erythropoietin has proven to be a major task because ofthe lability
of the purified moiety and insufficient quantities of initial raw material (e.g., urine
from anemic patients or plasma from anemic sheep). The purification of Ep has,
however, been achieved by Miyake et al. [4]. This material from urines voided by
aplastic anemic patients contained 79,000 units of Ep activity per mg of protein with
a molecular weight of39,000 to 40,000. It produced a single band on gel electrophore-
sis at pH 6 in the presence of 0.05 percent Triton X-100, and yielded a single band on
gel electrophoresis at pH 7 in the presence of sodium dodecylsulfate and mercaptoe-
thanol.
Recent reports have described that contaminated preparations of erythropoietin
exist and have discussed their possible effects on hematopoiesis [5]. The following
report describes enhancement in erythropoietin activity in vitro after erythropoietin
preparations were subjected to sterilization with silver filters, Nalgene filters, or
membrane dialysis. Such treatment potentiated the ability of Ep preparations to
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stimulate murine progenitor cells to form erythroid colonies in culture, and at the
same time did not alter the specific activity of Ep when assayed in the exhypoxic,
polycythemic mouse bioassay. On the other hand, Millipore filtration resulted in a
loss of Ep specific activity both in vitro by reducing the number of erythroid colony
forming cells (CFU-e and BFU-e) from normal mouse marrow and in vivo as
measured in the Ep mouse bioassay.
MATERIALS AND METHODS
Mice
BDF, male (23-28 gm, Charles River Breeding Labs, Wilmington, MA) were kept
in standard plastic cages and fed Purina Lab Chow and water ad libitum. Mice were
sacrificed by cervical dislocation. The femurs were excised and the bone marrow cells
flushed and suspended in alpha medium (Flow Laboratories, Inc., Rockville, MD).
Single cell suspensions were made using a tuberculin syringe with a 23 gauge needle,
spun at 2,000 rpm for five minutes and appropriately diluted with alpha medium.
Assayfor CFU-e and BFU-e
Culture assays for erythroid precursors were carried out in a methylcellulose
system as already described [6,7]. A concentration of2 x 105 cells per ml was plated in
plastic 35 mm tissue culture dishes (Lux Standard, No. 5221-R, Flow). No fewer than
eight replicate plates per assay point were used. Media consisted of alpha medium
(Flow), 0.8 percent methylcellulose (Fisher Scientific Co., Norcross, GA), 1 percent
bovine serum albumin (Calbiochem, San Diego, CA), 30 percent fetal bovine serum
(Batch No. 40511240, Flow), 10-4 M 2-mercaptoethanol in a final volume of one ml.
Four different preparations of erythropoietin were used: sheep plasma, Step III Ep
[5.88 International Units (IU) per mg; Connaught Laboratories, Willowdale, On-
tario, Canada]; WHO-International Reference Preparation (2 IU per mg); and two
different human urinary extracts designated "MU-3" (34 IU per mg) and "M-7" (16
IU per mg).'
The cell cultures were incubated at 370C in a humidified atmosphere flushed with 5
percent CO2 in air. Colonies were stained and identified as erythroid bythe improved
benzidine staining method ofGallicchio and Murphy[8] and scored using an inverted
microscope (Wild, Heerbrugg, Switzerland) at 40x magnification. For higher resolu-
tion light microscopy, individual colonies were plucked from the culture plate and
cytocentrifuged (Cytospin, Shandon-Elliot, Sewickley, PA) at 500 rpm for five
minutes and examined after Wright/Giemsa counter staining.
Step III, MU-3, and M-7 erythropoietin preparations were individually dissolved
in alpha medium and then subjected to continuous dialysis (Spectraphor membrane
tubing, cylindrical diameter 14.6 mm, MW cutoff 6,000-8,000, Spectrum Medical
Industries, Inc., Los Angeles, CA) against alpha medium for 24 hours at 4°C. The
dialysis medium (i.e., dialysate) was changed after four hours; the ratio of the
dialysate to dialysand was 15:1. Protein determinations before and after analysis were
performed using the method of Lowry [9]. Normal murine marrow cells were plated
in the presence of varying concentrations of either dialyzed or non-dialyzed erythro-
poietin (i.e., 0.25 to 2.0 IU per ml). Samples of erythropoietin were assayed for Ep
M-7 was collected and concentrated by Centro de Estudios Farmacologicos y de Principios Naturales,
Buenos Aires, Argentina, further processed and assayed by Hematology Research Laboratories, Childrens
Hospital of Los Angeles, under Research Grant HL-10880 of NHLBI.
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activity in the exhypoxic, polycythemic mouse bioassay of Camiscoli and Gordon
[10].
The erythropoietin preparations were also sterilized by membrane filtration using
Nalgene (0.45 ,um pore size, polystyrene nitrocellulose composition, Nalge Corp.,
Rochester, NY), Millipore [0.45 ,um, (type HA) mixed ester ofcellulose composition,
Ashley, MA] or Selas filters (0.45 jgm, silver metal membranes, Selas Corp.,
Huntington Valley, PA).
P values were determined using a two-tailed Student's t test. P values greater than
0.06 were not considered significant, and these actual values are, therefore, omitted in
the tabular data.
RESULTS
The in vitro production of erythroid colonies derived from normal murine marrow
cells cultured in the presence of four different concentrations of either non-dialyzed
or dialyzed erythropoietin is given in Table 1. Dialyzed erythropoietin preparations
produced a greater number of erythroid colonies than non-dialyzed preparations.
However, neither dialyzed nor non-dialyzed erythropoietin was able to stimulate as
many erythroid colonies as the non-dialyzed WHO-International Reference Prepara-
tion. This suggests that the WHO reference material is relatively free from contami-
nants associated with the other erythropoietin preparations and is, therefore, ideally
suited as the standard reference material. There was no substantial protein loss
during dialysis (e.g., MU-3 before dialysis = 3.88 mg of protein per ml and after
dialysis = 3.86 mg of protein per ml).
Erythropoietin preparations sterilized by passage through Millipore filters had
reduced biological activity when compared with Ep preparations sterilized by
TABLE I
Effects of Membrane Dialysis on In Vitro Activity of Erythropoietin
CFU-ea BFU-ea
Erythropoietin Ep units/plate non-Db DI (P<) non-Db DI
Sheep Plasma, Step III 0.25 29 4 6 46 i 6 1 + 1 7 + 2
(5.8 IU/mg) 0.50 51 :fi 4 62 7 11 1 14 5
1.00 63 5 73 7 16 5 21 2
2.00 71 4 89 5 (0.01) 19 1 24 -45
Human Urinary 0.25 22 i 5 38 3 9 2 13 3
MU-3 (34 IU/mg) 0.50 38 4 46 5 13 3 16 5
1.00 59 3 68 7 18 2 22 2
2.00 86 6 105 7 (0.02) 23 2 26 5
Human Urinary 0.25 19 5 25 2 3 1 3 1
M-7 (16 IU/mg) 0.50 26 5 51 3 6 2 9 1
1.00 61 4 84 5 17 2 23+2
2.00 101 5 129 6 (0.06) 25 1 30 i 4
WHO-Reference Preparation 0.25 44 h 3 14 + 5
(2 IU/mg) 0.50 90 7 18 + 5
1.00 III 6 24 2
2.00 160 8 36 5
aPer 2 x 105 nucleated bone marrow cells/plate; Mean
bNon-dialyzed erythropoietin.
cDialyzed erythropoietin.
S.E. of 8 culture plates/point.
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Nalgene filtration or Selas silver filtration as determined by the exhypoxic, polycy-
themic mouse bioassay (Table 2). This in vivo assay was confirmed and extended by
the impaired ability of such Millipore sterilized material to induce erythroid colony
formation in vitro (Table 3).
DISCUSSION
The various contaminants in erythropoietin preparations and the subsequent
anomalous effects these moieties may exert on hematopoiesis is of considerable
concern. Studies employing Millipore filtration for sterilization of both erythropoie-
tin and colony stimulating activity have reported loss of both factors [11-14]. We
now report that Millipore filtered Ep preparations had a reduced capacity to produce
CFU-e derived colonies in culture and also a reduced 59Fe incorporation into red
blood cells when measured in the Ep mouse bioassay. Human Ep preparation M-7,
treated by whatever means, demonstrated no interference with the development of
BFU-e derived bursts. The latter datum is consonate with the proposition that P,FU-e
are relatively insensitive to Ep but are dependent on an imperfectly defined factor(s),
"burst promoting activity" (BPA) [15,16]. CFU-e, on the other hand, are exquisitely
sensitive to, and their viability in vitro is reliant upon, Ep [15]. The loss of Ep
following Millipore filtration lends support to both ofthese contentions and indicates
that BPA is not removed by Millipore filtration as is Ep.
The treatment of Ep by membrane dialysis prior to its in vitro use indicates that
dialysis of Ep can significantly improve the plating efficiency of both CFU-e and
BFU-e at 2 IU Ep (p value < 0.01-0.06). Such membrane dialysis treatment removes
small molecules which may be inhibitors present in such Ep preparation. Routine
membrane dialysis treatment of Ep prior to employment in murine clonal cell
cultures has already been recommended byOgawa[17]. The exact chemical nature of
these dialyzable and unwanted moieties remains, however, to be established.
The exact means whereby Millipore filters resulted in a loss of Ep activity is still
not clear. It has been suggested that the composition of the filters themselves may
TABLE 2
In Vivo Bioassay of Erythropoietin
%o 59Fe Retention of
incorporated in Ep Activity
Test Material RBCa (No)
0.20 IU (MU-3) 15.42 + 1.31 100
Erythropoietin
(Nalgene Filtered)
0.20 IU (MU-3) 16.50 + 1.03 100
Erythropoietin
(Selas Filtered)
0.20 IU (MU-3) 9.07 f 0.55 59
Erythropoietin
(Millipore Filtered)
0.20 IU (MU-3) 12.20 + 0.38 100
Erythropoietin
(Unfiltered)
Alpha Medium 1.02 + 0.37
aMean + S.E. of 10 assay mice per point.
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TABLE 3
Comparison of Membrane Filtration-Sterilization on Erythroid Colony Formation
CFU-eb BFU-eb
Epa Filtration-Sterilization Filtration-Sterilization
Concentration
(IU/ml) Millipore Selas P< Millipore Selas
0.25 3 I I0 2 1 1 3 1
0.50 15 2 26 4 5 2 9 2
1.00 35 4 60 6 (0.01) 14 3 17 3
2.00 87 7 121 8 (0.01) 27 4 35 4
aEp: M-7 with a specific activity of 16 IU/mg.
bPer 2 x 105 nucleated bone marrow cells/plate; mean i S.E. of 8 culture plates/point.
contribute to the resultant loss of Ep activity. Millipore filters used in these studies
contained mixed esters of cellulose, whereas Nalgene filters were of nitrocellulose
composition. This may explain the observed differences. Other studies [18] have doc-
umented the presence of non-ionic detergents, such as Triton X-100, impregnating
Millipore filters. Lowy and Keighley [13] have, however, shown that these detergents
alone are not solely responsible for the loss ofEp with Millipore filters since washing
the filters free of detergents still resulted in a loss ofEp activity. Their work indicates
that the high concentration of tryptophan, an amino acid that Ep contains, is
selectively bound to the Millipore filters.
Heretofore, all the reported studies which have been performed reflected the
inability of Millipore treated Ep preparations to influence 59Fe incorporation in
diffusion chambers [12] or 59Fe incorporation into erythrocytes [13]; however, no
documented studies have been reported comparing various filtered preparations
using the in vitro clonal erythroid stem cell assay. These present studies suggest that
prior treatment oferythropoietin by dialysis followed byeither Nalgene or silver filter
sterilization reduces contamination by as yet undefined substances without any loss
of Ep during filtration. It is suggested that Ep preparations for in vitro clonal stem
cell usage be treated in this manner until a supply of pure hormone becomes more
readily available.
ACKNOWLEDGMENTS
The authors express their appreciation to Dr. Albert S. Gordon, Ms. C. Gizzi, and Mr. R. Mahar for the
erythropoietin bioassays. These studies were supported by NIH grants AM-19741 and AM-07266, and the
Bob Hipple Memorial Committee for Cancer Research.
REFERENCES
1. Keighley G, Lowy PH: Chemistry and purification oferythropoietin. In Kidney Hormones. Edited by
JW Fisher. New York, Academic Press, 1971, pp 269-273
2. Gordon AS: Erythropoietin. Vitam Horm 31:105-174, 1973
3. Fisher JW: Erythropoietin: Pharmacology, biogenesis and control of production. Pharmacol Rev
24:459-508, 1972
4. Miyake T, Kung G, Goldwasser E: Purification ofhuman erythropoietin. J Biol Chem 252:5558-5564,
1974
5. Boggs DR: Correspondence. Blood 47:339, 1976
6. Iscove NN, Sieber F: Erythroid progenitors in mouse bone marrow detected by macroscopic colony
formation in culture. Exp Hematol 3:32-43, 1975254 GALLICCHIO AND MURPHY
7. Murphy MJ Jr, Sullivan ME: Culture of erythroid stem cells from murine and human marrow and
blood. In In Vitro Aspects of Erythropoiesis. Edited by MJ Murphy Jr. New York, Springer-Verlag,
1978, pp 262-275
8. Gallicchio VS, Murphy MJ Jr: Erythropoiesis in vitro II. Cytochemical enhancement of erythroid
stem cells (CFU-e and BFU-e) from normal mouse and human hematopoietic tissues. Exp Hematol
7:219-224, 1979
9. Lowry 0, Rosebrough NJ, Farr AL, et al: Protein measurements with the Folin phenol reagent. J Biol
Chem 193:265-275, 1951
10. Camiscoli JF, Gordon AS: Bioassay and standardization of erythropoietin. In Regulation of
Hematopoiesis, Vol 1. Edited by AS Gordon. New York, Appleton-Century-Croft, 1970, pp 369-383
11. Spivak JL, Levin J: Correspondence. Blood 50:549-550, 1977
12. Bergman I, Newby EJ: Erythropoietin response ofbone marrow cells cultivated in diffusion chambers.
Nature 213:300-301, 1967
13. Lowy P, Keighley G: Inactivation of erythropoietin by Koshland's tryptophan reagent and by
membrane filtration. Biochim Biophys Acta 160:413-419, 1968
14. Shadduck RK, Boegel F, Pope F, et al: Binding of colony stimulating factor by sterile filtration
membranes. Exp Hematol 8:355-360, 1978
15. Wagemaker G: Cellular and soluble factors influencing the differentiation of primitive erythroid
progenitor cells (BFU-e) in vitro. In In Vitro Aspects of Erythropoiesis. Edited by MJ Murphy Jr.
New York, Springer-Verlag, 1978, pp 44-57
16. Iscove NN, Guilbert LJ: Erythropoietin-independence of early erythropoiesis and a two-regulator
model of proliferative control in the hemopoietic system. In In Vitro Aspects of Erythropoiesis. Edited
by MJ Murphy Jr. New York, Springer-Verlag, 1978, pp 3-7
17. Ogawa M: Methylcellulose clonal cell culture of murine and human erythropoietic precursors. In In
Vitro Aspects of Erythropoiesis. Edited by MJ Murphy Jr. New York, Springer-Verlag, 1978. p 248
18. Cahn RD: Detergents in membranes. Science 155:195-196, 1967